错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury

  • B. Rohaut,
  • C. Calligaris,
  • B. Hermann,
  • P. Perez,
  • F. Faugeras,
  • F. Raimondo,
  • J-.R. King,
  • D. Engemann,
  • C. Marois,
  • L. Le Guennec,
  • L. Di Meglio,
  • A. Sangaré,
  • E. Munoz Musat,
  • M. Valente,
  • A. Ben Salah,
  • A. Demertzi,
  • L. Belloli,
  • D. Manasova,
  • L. Jodaitis,
  • M. O. Habert,
  • V. Lambrecq,
  • N. Pyatigorskaya,
  • D. Galanaud,
  • L. Puybasset,
  • N. Weiss,
  • S. Demeret,
  • F. X. Lejeune,
  • J. D. Sitt,
  • L. Naccache

摘要

Accurately predicting functional outcomes for unresponsive patients with acute brain injury is a medical, scientific and ethical challenge. This prospective study assesses how a multimodal approach combining various numbers of behavioral, neuroimaging and electrophysiological markers affects the performance of outcome predictions. We analyzed data from 349 patients admitted to a tertiary neurointensive care unit between 2009 and 2021, categorizing prognoses as good, uncertain or poor, and compared these predictions with observed outcomes using the Glasgow Outcome Scale–Extended (GOS-E, levels ranging from 1 to 8, with higher levels indicating better outcomes). After excluding cases with life-sustaining therapy withdrawal to mitigate the self-fulfilling prophecy bias, our findings reveal that a good prognosis, compared with a poor or uncertain one, is associated with better one-year functional outcomes (common odds ratio (95% CI) for higher GOS-E: OR = 14.57 (5.70–40.32), P < 0.001; and 2.9 (1.56–5.45), P < 0.001, respectively). Moreover, increasing the number of assessment modalities decreased uncertainty (OR = 0.35 (0.21–0.59), P < 0.001) and improved prognostic accuracy (OR = 2.72 (1.18–6.47), P = 0.011). Our results underscore the value of multimodal assessment in refining neuroprognostic precision, thereby offering a robust foundation for clinical decision-making processes for acutely brain-injured patients. ClinicalTrials.gov registration: NCT04534777.